Non-small cell lung cancer (NSCLC) is a very common solid tumor where only small advances in the reduction of relapse-free survival and overall survival have been accomplished. The issue is particular

NIAID Data Ecosystem40

Interleukin-10 Haplotype May Predict Survival and Relapse in Resected Non-Small Cell Lung Cancer

肺癌预后

IL-10单倍型分析

IL-10 is associated with tumor malignancy via immune escape. We hypothesized that IL-10 haplotypes categorized by IL-10 promoter polymorphisms at –1082A>G, –819C>T, and –592C>A might influence IL-10 e

Figshare2016-01-19 更新10

Table_1_ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC.xlsx

肿瘤免疫治疗生物标志物

肺癌预后

Immunotherapy by immune checkpoint inhibitors (ICIs) has showed outstanding efficacy in the treatment of advanced non-small cell lung cancer (NSCLC). The combination of immunotherapy with anti-angioge

NIAID Data Ecosystem40

The results of meta-analysis on NSCLC overall survival and p16 methylation.

肺癌预后

表观遗传生物标志物

MSP, Methylation-specific PCR; Q-MSP, quantitative methylation-specific PCR; FFPE, formalin-fixed paraffin-embedded; ADC, adenocarcinoma; Pts, patients.

Figshare2015-12-02 更新10

Raw data.zip

资源简介：

相关数据集